WO1992021768A1 - Analytical methods - Google Patents

Analytical methods Download PDF

Info

Publication number
WO1992021768A1
WO1992021768A1 PCT/GB1992/000991 GB9200991W WO9221768A1 WO 1992021768 A1 WO1992021768 A1 WO 1992021768A1 GB 9200991 W GB9200991 W GB 9200991W WO 9221768 A1 WO9221768 A1 WO 9221768A1
Authority
WO
WIPO (PCT)
Prior art keywords
substrate
enzyme
biosensor
reaction product
analyte
Prior art date
Application number
PCT/GB1992/000991
Other languages
French (fr)
Inventor
Denise Vera Pollard-Knight
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Priority to US08/157,079 priority Critical patent/US5496701A/en
Priority to JP4509874A priority patent/JPH06507708A/en
Publication of WO1992021768A1 publication Critical patent/WO1992021768A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/808Optical sensing apparatus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property

Definitions

  • This invention relates to methods for the qualitative or quantitative determination of biomolecules in solution, in particular to methods for the determination of enzymes and their substrates in samples of biological origin.
  • biosensors include a sensitised coating layer which is located in the evanescent region of a resonant field.
  • Detection of the analyte typically utilizes optical techniques such as, for example, surface plasmon resonance (SPR) , and is based on changes in the thickness and/or refractive index of the coating layer resulting from interaction of that layer with the analyte. This causes a change, eg in the angular position of the resonance.
  • SPR surface plasmon resonance
  • optical biosensors include a waveguide in which a beam of light is propagated. The optical characteristics of the device are influenced by changes occurring at the surface of the waveguide.
  • One form of optical biosensor is based on frustrated total reflection.
  • the principles of frustrated total reflection (FTR) are well-known; the technique is described, for example, by Bosacchi and Oehrle [Applied Optics (1982), 2 , 2167-2173].
  • An FTR device for use in immunoassay is disclosed in US Patent 4,857,273 and comprises a cavity layer bounded on one side by the sample under investigation and on the other side by a spacer layer which in turn is mounted on a substrate.
  • the substrate-spacer layer interface is irradiated with monochromatic radiation such that total reflection occurs, the associated evanescent field penetrating through the spacer layer. If the thickness of the spacer layer is correct and the incident parallel wave vector matches one of the resonant mode propagation constants, the total reflection is frustrated and radiation is coupled into the cavity layer.
  • the cavity layer must be composed of material which has a higher refractive index than the spacer layer and which is transparent at the wavelength of the incident radiation.
  • FTR biosensors have been described [see, for example, PCT Patent Application WO 90/06503] in which the cavity layer is a thin film of relatively high refractive index material, typically an inorganic oxide.
  • the sensitised coating layer comprise a layer of immobilised chemical or biochemical species.
  • Methods have been disclosed [see PCT Patent Application No WO 90/11510] for the determination of one member of an enzyme-substrate pair which comprise immobilising the other member of that pair on the surface of an SPR biosensor and monitoring the effect of deposition of the reaction product on the surface of the device.
  • the reaction product must be insoluble and this places great constraints on the range of enzymes and substrates which may be determined by this method.
  • the deposition of the insoluble product on the surface means that the device is generally not re-usable.
  • a method of determining one member of an enzyme-substrate pair which comprises bringing the members of the pair into contact so as to form, directly or indirectly, an absorbing reaction product at or in the vicinity of the surface of an optical waveguide biosensor.
  • the method of the invention is advantageous in that enzymes and substrates which produce soluble, absorbing reaction products are more widely available than those which produce insoluble products. This means that the number of enzymes and substrates which can be directly assayed is significantly greater. In many cases appropriate substrates can be easily synthesised de novo, which is not the case for substrates which result in insoluble products. Also, if it is the enzyme which is immobilised on the sensor surface, and if the enzymes maintain their activity, the sensor can be re-used for several samples. Again, this is not the case for insoluble reaction products.
  • any convenient parameter of the emitted radiation may be monitored. Obviously, the absorbing nature of the reaction product will have an effect on the intensity of the radiation coupled out of the waveguide.
  • the product may also be fluorescent or luminescent and it may be the fluorescence or luminescence which is monitored.
  • One specific embodiment of the method according to the invention comprises the steps of a) contacting a sample, in which the analyte is to be determined, with the surface of an optical waveguide biosensor on which the other member of the enzyme-substrate pair is immobilised, so as to form (if the analyte is present) a soluble, absorbing reaction product, b) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and c) monitoring the radiation emitted from the biosensor.
  • the method of the invention may also be used to determine analytes which influence the rate of the enzyme-substrate reaction, ie enzyme inhibitors and activators.
  • the method may comprise a) contacting a sample, in which an inhibitor or activator of an enzyme is to be determined, with the surface of an optical waveguide biosensor on which an enzyme or a substrate therefor is immobilised, the substrate being one which in the presence of the enzyme produces a soluble, absorbing reaction produc , b) adding to the sample the other member of the enzyme- substrate pair, c) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and d) monitoring the radiation emitted from the biosensor.
  • the formation of absorbing reaction product correlates with the concentration of activator in the sample, or correlates inversely with the concentration of inhibitor.
  • a substrate analogue which does do so may be added to the sample before contacting it with the sensor surface.
  • the substrate analogue then competes with the natural substrate for binding to the immobilised enzyme.
  • the invention also provides a method for determining one member of an enzyme-substrate pair (the analyte) , which comprises a) contacting a sample, in which the analyte is to be determined, with the surface of an optical waveguide biosensor on which a second enzyme is immobilised, b) adding to the sample the other member of the enzyme- substrate pair and a substrate for the immobilised enzyme which, in the presence of a reaction product of the enzyme- substrate pair, produces a soluble, absorbing reaction product, c) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and d) monitoring the radiation emitted from the biosensor.
  • both enzymes may be immobilised on the sensor surface.
  • One enzyme reacts with the substrate in the sample to produce a product which in the presence of the substrate for the second enzyme reacts to form the absorbing, soluble reaction product.
  • the soluble reaction products must not diffuse out of the evanescent field of the optical waveguide sensor during the course of the assay, but must remain localised close to the immobilised enzyme. This is known to occur for some enzymes.
  • the luminescent signal produced remains localised close to the enzyme active site.
  • the reaction product may be kept within the evanescent field by means of a physical barrier or by capture on the sensor surface by means of an antibody.
  • antibodies may be prepared which bind the product of the enzyme reaction but not the substrate. The antibodies may be immobilised on the same chip as the enzymes.
  • reaction products are constrained to the vicinity of the surface at which they are formed, it may be possible to detect several analytes within the same sample.
  • Assays for some enzymes may be performed by observing a decrease in the absorbance at a particular wavelength.
  • angiotensin converting enzyme may be assayed with the substrate FA-Phe-Gly-Gly (FA is furylacryloyl) by observing a decrease in absorbance.
  • Enzymes for which there are no suitable substrates for direct measurement may be detected by the use of a coupling enzyme.
  • oxalate oxidase may be detected as follows:
  • ⁇ reatine kinase or phosphocreatine may be assayed as follows:
  • a resonant biosensor based on the principle of frustrated total reflection (FTR) .
  • FTR frustrated total reflection
  • Such a biosensor typically comprises a) a cavity layer of dielectric material of refractive index n 3 , b) a dielectric substrate of refractive index n lf and c) interposed between the cavity layer and the substrate, a dielectric spacer layer of refractive index n 2 .
  • the interface between the substrate and the spacer layer is irradiated with light such that total reflection occurs.
  • 'light' may include not only visible light but also wavelengths above and below this range, eg in the ultra-violet and infra-red.
  • Resonant propagation of a guided mode in the cavity layer will occur, for a given wavelength, at a particular angle of incidence of the exciting radiation.
  • two basic measurement approaches are possible: scanning the angle of incidence at fixed wavelength or scanning the wavelength at a fixed angle of incidence.
  • the former approach using monochromatic radiation, is preferred since it allows the use of a laser source, simplifying the problem of optical collimation, and avoids dispersion effects, thereby simplifying the analysis of the results.
  • the angular position of the resonant effect depends on various parameters of the biosensor device, such as the refractive .ndices and thicknesses of the various layers. In general, it is a pre-requisite that the refractive index n 3 of the cavity layer and the refractive index n x of the substrate should both exceed the refractive index n 2 of the spacer layer. Also, since at least one mode must exist in the cavity to achieve resonance, the cavity layer must exceed a certain minimum thickness.
  • the cavity layer is preferably a thin-film of dielectric material.
  • transmissive dielectric materials for the cavity layer include zirconium dioxide, titanium dioxide, aluminium oxide and tantalum oxide.
  • the cavity layer may be prepared by known techniques, eg vacuum evaporation, sputtering, chemical vapour deposition or in-diffusion.
  • the dielectric spacer layer must also be suitably transmissive to the incident radiation and must have a lower refractive index than both the cavity layer and the substrate.
  • the layer may, for example, comprise an evaporated or sputtered layer of magnesium fluoride.
  • an infra-red light injection laser may be used as light source.
  • the light from such a source typically has a wavelength around 800nm.
  • suitable materials include lithium fluoride and silicon dioxide.
  • the spacer layer may be deposited on the substrate by a sol-gel process, or be formed by chemical reaction with the substrate.
  • the refractive index of the substrate (n x ) must be greater than that (n 2 ) of the spacer layer but the thickness of the substrate is generally not critical to the performance of the inventio .
  • the spacer layer will typically have a thickness of the order of several hundred nanometres, say from about 200nm to 2000nm, more preferably 500 to 1500nm, eg lOOOnm.
  • the cavity layer typically has a thickness of a few tens of nanometres, say 10 to 200nm, more preferably 30 to 150nm, eg lOOn .
  • the cavity layer has a thickness of 30 to 150nm and comprises a material selected from zirconium dioxide, hafnia, silicon nitride, titanium dioxide, tantalum oxide and aluminium oxide
  • the spacer layer has a thickness of 500 to 1500nm and comprises a material selected from magnesium fluoride, lithium fluoride and silicon dioxide, the choice of materials being such that the refractive index of the spacer layer is less than that of the cavity layer.
  • Preferred materials for the cavity layer and the spacer layer are tantalum oxide and silicon dioxide respectively.
  • any convenient source of radiation may be used as the source of the incident light but it is preferable to use monochromatic radiation and the most convenient source of such radiation is a laser.
  • the choice of laser will depend inter alia on the materials used for the various layers of which some examples have already been given, and of course on the particular absorbing reaction product.
  • the scanning of angle may be performed either sequentially or simultaneously ie by varying the angle of incidence of a parallel beam of light or by simultaneously irradiating over a range of angles using a fan-shaped beam of light as described (in connection with SPR) in European Patent Application No 0305109A.
  • a single-channel detector may be used which is mechanically scanned over a range of angles; in the latter case, in which a range of angles is irradiated simultaneously, it will generally be necessary to use a multi-channel detector having angular resolution.
  • the incident light is coupled into the cavity layer by FTR, propagates a certain distance along the cavity layer, and couples back out (also by FTR) .
  • the propagation distance depends on the various device parameters but is typically of the order of 1 or 2mm.
  • the formation of absorbing reaction product in the course of the methods according to the invention may result in a reduction in the intensity of the reflected light. If the reaction product is fluorescent or luminescent, the increase in intensity at the fluorescent or luminescent wavelengths may be used to determine the analyte.
  • Figure 1 shows schematically an assay method for the determination of an enzyme El.
  • a substrate SI for the enzyme is immobilised on the surface of the cavity layer C of an FTR biosensor.
  • the substrate SI may be immobilised directly on the layer C or may be immobilised in a layer of gel.
  • a detectable (absorbing) product Pi is produced.
  • Figure 2 shows a corresponding method for the determination of a substrate S.
  • the enzyme E which is immobilised on the sensor surface C.
  • a coupling enzyme E2 is immobilised on the surface C.
  • a substrate SI for that enzyme and a substrate S2 for the coupling enzyme E2 which in the presence of the product Pi (produced from Si by the action of El) produces a detectable (absorbing) product P2.
  • Figure 4 shows a scheme in which the substrate Si is the analyte and two enzymes El and E2 are immobilised on the sensor C.
  • a coupling substrate S2 is added to the sample containing SI.
  • the analyte substrate SI is converted by enzyme El to a product PI which reacts, in the presence of enzyme E2, with the coupling substrate S2 to produce a detectable (absorbing product) P2.
  • Figure 5 shows a variation on the scheme shown in Figure 2 in which the reaction product P is captured and retained at the surface C of the sensor by immobilised specific antibodies.

Abstract

A method for determining one member of an enzyme-substrate pair (the analyte), comprises bringing the members of the pair into contact so as to form, directly or indirectly, an absorbing reaction product at or in the vicinity of the surface of an optical waveguide biosensor. The biosensor is preferably a resonant optical biosensor based on the principle of frustrated total reflection.

Description

Title : Analytical Methods
This invention relates to methods for the qualitative or quantitative determination of biomolecules in solution, in particular to methods for the determination of enzymes and their substrates in samples of biological origin.
Many devices for the automatic determination of biochemical analytes in solution have been proposed in recent years. Typically, such devices (biosensors) include a sensitised coating layer which is located in the evanescent region of a resonant field. Detection of the analyte typically utilizes optical techniques such as, for example, surface plasmon resonance (SPR) , and is based on changes in the thickness and/or refractive index of the coating layer resulting from interaction of that layer with the analyte. This causes a change, eg in the angular position of the resonance.
Other optical biosensors include a waveguide in which a beam of light is propagated. The optical characteristics of the device are influenced by changes occurring at the surface of the waveguide. One form of optical biosensor is based on frustrated total reflection. The principles of frustrated total reflection (FTR) are well-known; the technique is described, for example, by Bosacchi and Oehrle [Applied Optics (1982), 2 , 2167-2173]. An FTR device for use in immunoassay is disclosed in US Patent 4,857,273 and comprises a cavity layer bounded on one side by the sample under investigation and on the other side by a spacer layer which in turn is mounted on a substrate. The substrate-spacer layer interface is irradiated with monochromatic radiation such that total reflection occurs, the associated evanescent field penetrating through the spacer layer. If the thickness of the spacer layer is correct and the incident parallel wave vector matches one of the resonant mode propagation constants, the total reflection is frustrated and radiation is coupled into the cavity layer. The cavity layer must be composed of material which has a higher refractive index than the spacer layer and which is transparent at the wavelength of the incident radiation.
More recently, FTR biosensors have been described [see, for example, PCT Patent Application WO 90/06503] in which the cavity layer is a thin film of relatively high refractive index material, typically an inorganic oxide.
In all biosensors, it is necessary that the sensitised coating layer comprise a layer of immobilised chemical or biochemical species. Methods have been disclosed [see PCT Patent Application No WO 90/11510] for the determination of one member of an enzyme-substrate pair which comprise immobilising the other member of that pair on the surface of an SPR biosensor and monitoring the effect of deposition of the reaction product on the surface of the device. Obviously, to have an effect on the characteristics of the device, the reaction product must be insoluble and this places great constraints on the range of enzymes and substrates which may be determined by this method. Also, the deposition of the insoluble product on the surface means that the device is generally not re-usable.
We have now devised methods of determining enzymes and their substrates using a biosensor which overcome or substantially mitigate these disadvantages.
According to the invention, there is provided a method of determining one member of an enzyme-substrate pair (the analyte) , which comprises bringing the members of the pair into contact so as to form, directly or indirectly, an absorbing reaction product at or in the vicinity of the surface of an optical waveguide biosensor.
The method of the invention is advantageous in that enzymes and substrates which produce soluble, absorbing reaction products are more widely available than those which produce insoluble products. This means that the number of enzymes and substrates which can be directly assayed is significantly greater. In many cases appropriate substrates can be easily synthesised de novo, which is not the case for substrates which result in insoluble products. Also, if it is the enzyme which is immobilised on the sensor surface, and if the enzymes maintain their activity, the sensor can be re-used for several samples. Again, this is not the case for insoluble reaction products.
Any convenient parameter of the emitted radiation may be monitored. Obviously, the absorbing nature of the reaction product will have an effect on the intensity of the radiation coupled out of the waveguide. The product may also be fluorescent or luminescent and it may be the fluorescence or luminescence which is monitored.
One specific embodiment of the method according to the invention comprises the steps of a) contacting a sample, in which the analyte is to be determined, with the surface of an optical waveguide biosensor on which the other member of the enzyme-substrate pair is immobilised, so as to form (if the analyte is present) a soluble, absorbing reaction product, b) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and c) monitoring the radiation emitted from the biosensor.
The method of the invention may also be used to determine analytes which influence the rate of the enzyme-substrate reaction, ie enzyme inhibitors and activators. In this case, the method may comprise a) contacting a sample, in which an inhibitor or activator of an enzyme is to be determined, with the surface of an optical waveguide biosensor on which an enzyme or a substrate therefor is immobilised, the substrate being one which in the presence of the enzyme produces a soluble, absorbing reaction produc , b) adding to the sample the other member of the enzyme- substrate pair, c) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and d) monitoring the radiation emitted from the biosensor.
In this method, the formation of absorbing reaction product correlates with the concentration of activator in the sample, or correlates inversely with the concentration of inhibitor.
In a variation on the method of the invention, where the analyte is the substrate which does not produce an absorbing reaction product, a substrate analogue which does do so may be added to the sample before contacting it with the sensor surface. The substrate analogue then competes with the natural substrate for binding to the immobilised enzyme.
In another variation, the invention also provides a method for determining one member of an enzyme-substrate pair (the analyte) , which comprises a) contacting a sample, in which the analyte is to be determined, with the surface of an optical waveguide biosensor on which a second enzyme is immobilised, b) adding to the sample the other member of the enzyme- substrate pair and a substrate for the immobilised enzyme which, in the presence of a reaction product of the enzyme- substrate pair, produces a soluble, absorbing reaction product, c) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and d) monitoring the radiation emitted from the biosensor.
Where the analyte is the substrate, both enzymes may be immobilised on the sensor surface. One enzyme reacts with the substrate in the sample to produce a product which in the presence of the substrate for the second enzyme reacts to form the absorbing, soluble reaction product.
The soluble reaction products must not diffuse out of the evanescent field of the optical waveguide sensor during the course of the assay, but must remain localised close to the immobilised enzyme. This is known to occur for some enzymes. For example, in the assay of alkaline phosphatase using the substrate dioxetane phosphate in the presence of a detergent- solubilised derivative of fluorescein [Schaap et al (1989) Clin Chem J35., 1863-1864], the luminescent signal produced remains localised close to the enzyme active site. For those enzymes for which this is not the case the reaction product may be kept within the evanescent field by means of a physical barrier or by capture on the sensor surface by means of an antibody. For example, antibodies may be prepared which bind the product of the enzyme reaction but not the substrate. The antibodies may be immobilised on the same chip as the enzymes.
If the reaction products are constrained to the vicinity of the surface at which they are formed, it may be possible to detect several analytes within the same sample.
Examples of some suitable enzyme-substrate pairs are the following:
Absorbing product β-galactosidase resorufin-β-D-galactopyranoside β-galactosidase methoxy-1-naphthyl-β-D- galactopyranoside β-glucuronidase resorufin-β-D-glucuronide Fluorescent product siayltransferases cytidine-5-monophosphate-(3- fluoresceinyl-thioureido)-deoxy-N- acetyl-neuramic acid β-galactosidase fluorescein di-(β-D- galactopyranoside) Luminescent product alkaline phosphatase dioxetane phosphate in the presence of a detergent-solubilised derivative fluorescein firefly luciferase ATP and luciferin
Assays for some enzymes may be performed by observing a decrease in the absorbance at a particular wavelength. For example, angiotensin converting enzyme may be assayed with the substrate FA-Phe-Gly-Gly (FA is furylacryloyl) by observing a decrease in absorbance.
Enzymes for which there are no suitable substrates for direct measurement may be detected by the use of a coupling enzyme. For example, oxalate oxidase may be detected as follows:
(COOH) - + 02 > 2C02 + H202 oxalate oxidase
H202 + MBTH + DMA > Indamine dye + 2H20 peroxidase
MBTH — 3-methyl-2-benzothiazolinone hydrazone DMA ■*■** N,N-dimethylaniline
Alternatively, a suitable, simple chemical reaction which uses the reaction product to produce an absorbing species may be available. For example, σreatine kinase or phosphocreatine may be assayed as follows:
phosphocreatine + ADP > creatinine + ATP creatinine kinase creatinine + naphthol + diacetyl > pink complex The methods according to the invention may be conducted with any form of optical waveguide biosensor. However, it is preferred to use a resonant biosensor based on the principle of frustrated total reflection (FTR) . Such a biosensor typically comprises a) a cavity layer of dielectric material of refractive index n3, b) a dielectric substrate of refractive index nlf and c) interposed between the cavity layer and the substrate, a dielectric spacer layer of refractive index n2.
In use, the interface between the substrate and the spacer layer is irradiated with light such that total reflection occurs. In this context, 'light' may include not only visible light but also wavelengths above and below this range, eg in the ultra-violet and infra-red.
Resonant propagation of a guided mode in the cavity layer will occur, for a given wavelength, at a particular angle of incidence of the exciting radiation. Thus, two basic measurement approaches are possible: scanning the angle of incidence at fixed wavelength or scanning the wavelength at a fixed angle of incidence. The former approach, using monochromatic radiation, is preferred since it allows the use of a laser source, simplifying the problem of optical collimation, and avoids dispersion effects, thereby simplifying the analysis of the results.
The angular position of the resonant effect depends on various parameters of the biosensor device, such as the refractive .ndices and thicknesses of the various layers. In general, it is a pre-requisite that the refractive index n3 of the cavity layer and the refractive index nx of the substrate should both exceed the refractive index n2 of the spacer layer. Also, since at least one mode must exist in the cavity to achieve resonance, the cavity layer must exceed a certain minimum thickness. The cavity layer is preferably a thin-film of dielectric material. Suitably transmissive dielectric materials for the cavity layer include zirconium dioxide, titanium dioxide, aluminium oxide and tantalum oxide.
The cavity layer may be prepared by known techniques, eg vacuum evaporation, sputtering, chemical vapour deposition or in-diffusion.
The dielectric spacer layer must also be suitably transmissive to the incident radiation and must have a lower refractive index than both the cavity layer and the substrate. The layer may, for example, comprise an evaporated or sputtered layer of magnesium fluoride. In this case an infra-red light injection laser may be used as light source. The light from such a source typically has a wavelength around 800nm. Other suitable materials include lithium fluoride and silicon dioxide. Apart from the evaporation and sputtering techniques mentioned above, the spacer layer may be deposited on the substrate by a sol-gel process, or be formed by chemical reaction with the substrate.
The refractive index of the substrate (nx) must be greater than that (n2) of the spacer layer but the thickness of the substrate is generally not critical to the performance of the inventio .
By contrast, the thickness of the cavity layer must be so chosen that resonance occurs within an appropriate range of coupling angles. The spacer layer will typically have a thickness of the order of several hundred nanometres, say from about 200nm to 2000nm, more preferably 500 to 1500nm, eg lOOOnm. The cavity layer typically has a thickness of a few tens of nanometres, say 10 to 200nm, more preferably 30 to 150nm, eg lOOn .
It is particularly preferred that the cavity layer has a thickness of 30 to 150nm and comprises a material selected from zirconium dioxide, hafnia, silicon nitride, titanium dioxide, tantalum oxide and aluminium oxide, and the spacer layer has a thickness of 500 to 1500nm and comprises a material selected from magnesium fluoride, lithium fluoride and silicon dioxide, the choice of materials being such that the refractive index of the spacer layer is less than that of the cavity layer.
Preferred materials for the cavity layer and the spacer layer are tantalum oxide and silicon dioxide respectively.
Any convenient source of radiation may be used as the source of the incident light but it is preferable to use monochromatic radiation and the most convenient source of such radiation is a laser. The choice of laser will depend inter alia on the materials used for the various layers of which some examples have already been given, and of course on the particular absorbing reaction product.
The scanning of angle may be performed either sequentially or simultaneously ie by varying the angle of incidence of a parallel beam of light or by simultaneously irradiating over a range of angles using a fan-shaped beam of light as described (in connection with SPR) in European Patent Application No 0305109A. In the former case, a single-channel detector may be used which is mechanically scanned over a range of angles; in the latter case, in which a range of angles is irradiated simultaneously, it will generally be necessary to use a multi-channel detector having angular resolution.
At resonance, the incident light is coupled into the cavity layer by FTR, propagates a certain distance along the cavity layer, and couples back out (also by FTR) . The propagation distance depends on the various device parameters but is typically of the order of 1 or 2mm. The formation of absorbing reaction product in the course of the methods according to the invention may result in a reduction in the intensity of the reflected light. If the reaction product is fluorescent or luminescent, the increase in intensity at the fluorescent or luminescent wavelengths may be used to determine the analyte.
Some methods according to the invention will now be illustrated further with reference to the accompanying Figures.
Figure 1 shows schematically an assay method for the determination of an enzyme El. A substrate SI for the enzyme is immobilised on the surface of the cavity layer C of an FTR biosensor. The substrate SI may be immobilised directly on the layer C or may be immobilised in a layer of gel. When a sample containing the enzyme El is brought into contact with the biosensor surface C, a detectable (absorbing) product Pi is produced.
Figure 2 shows a corresponding method for the determination of a substrate S. In this case, it is the enzyme E which is immobilised on the sensor surface C.
In the scheme shown in Figure 3 for the determination of an enzyme El, a coupling enzyme E2 is immobilised on the surface C. To the sample containing El is added a substrate SI for that enzyme and a substrate S2 for the coupling enzyme E2 which in the presence of the product Pi (produced from Si by the action of El) produces a detectable (absorbing) product P2.
Figure 4 shows a scheme in which the substrate Si is the analyte and two enzymes El and E2 are immobilised on the sensor C. A coupling substrate S2 is added to the sample containing SI. The analyte substrate SI is converted by enzyme El to a product PI which reacts, in the presence of enzyme E2, with the coupling substrate S2 to produce a detectable (absorbing product) P2.
Figure 5 shows a variation on the scheme shown in Figure 2 in which the reaction product P is captured and retained at the surface C of the sensor by immobilised specific antibodies.

Claims

Claims
1. A method of determining one member of an enzyme-substrate pair (the analyte) , which comprises bringing the members of the pair into contact so as to form, directly or indirectly, an absorbing reaction product at or in the vicinity of the surface of an optical waveguide biosensor.
2. A method as claimed in Claim 1, which comprises the steps of a) contacting a sample, in which the analyte is to be determined, with the surface of an optical waveguide biosensor on which the other member of the enzyme-substrate pair is immobilised, so as to form (if the analyte is present) a soluble, absorbing reaction product, b) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and c) monitoring the radiation emitted from the biosensor.
3. A method as claimed in Claim 1, for the determination of an analyte which influences the rate of an enzyme-substrate reaction, which method comprises a) contacting a sample containing the analyte with the surface of an optical waveguide biosensor on which an enzyme or a substrate therefor is immobilised, the substrate being one which in the presence of the enzyme produces a soluble, absorbing reaction product, b) adding to the sample the other member of the enzyme- substrate pair, c) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and d) monitoring the radiation emitted from the biosensor.
4. A method as claimed in Claim 1, wherein the analyte is the substrate which does not produce an absorbing reaction product, and the method includes the further step of adding a substrate analogue which does do so to the sample before contacting it with the sensor surface.
5. A method as claimed in Claim 1, which comprises a) contacting a sample, in which the analyte is to be determined, with the surface of an optical waveguide biosensor on which a second enzyme is immobilised, b) adding to the sample the other member of the enzyme- substrate pair and a substrate for the immobilised enzyme which, in the presence of a reaction product of the enzyme- substrate pair, produces a soluble, absorbing reaction product, c) irradiating the biosensor with a beam of electromagnetic radiation such that propagation of light of a wavelength absorbed by the reaction product occurs within the waveguide, and d) monitoring the radiation emitted from the biosensor.
6. A method as claimed in Claim 5, wherein both enzymes are immobilised on the sensor surface.
7. A method as claimed in any one of the preceding claims, wherein reaction product is constrained in the vicinity of the sensor surface by means of a physical barrier or by capture on the sensor surface by means of an antibody.
8. A method as claimed in any one of the preceding claims, wherein the optical waveguide biosensor is a resonant biosensor based on the principle of frustrated total reflection comprising a) a cavity layer of dielectric material of refractive index n3, b) a dielectric substrate of refractive index n__, and c) interposed between the cavity layer and the substrate, a dielectric spacer layer of refractive index n2.
9. A method as claimed in Claim 8, wherein the cavity layer is a thin-film of dielectric material.
10. A method as claimed in Claim 8, wherein the cavity layer has a thickness of 30 to 150nm and comprises a material selected from zirconium dioxide, hafnia, silicon nitride, titanium dioxide, tantalum oxide and aluminium oxide, and the spacer layer has a thickness of 500 to 1500nm and comprises a material selected from magnesium fluoride, lithium fluoride and silicon dioxide, the choice of materials being such that the refractive index of the spacer layer is less than that of the cavity layer.
PCT/GB1992/000991 1991-06-04 1992-06-02 Analytical methods WO1992021768A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/157,079 US5496701A (en) 1991-06-04 1992-06-02 Optical biosensor method for determining an analyte
JP4509874A JPH06507708A (en) 1991-06-04 1992-06-02 Analysis method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9111912.3 1991-06-04
GB919111912A GB9111912D0 (en) 1991-06-04 1991-06-04 Analytical methods

Publications (1)

Publication Number Publication Date
WO1992021768A1 true WO1992021768A1 (en) 1992-12-10

Family

ID=10696009

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/000991 WO1992021768A1 (en) 1991-06-04 1992-06-02 Analytical methods

Country Status (5)

Country Link
US (1) US5496701A (en)
EP (1) EP0588831A1 (en)
JP (1) JPH06507708A (en)
GB (1) GB9111912D0 (en)
WO (1) WO1992021768A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025892A1 (en) * 1992-06-10 1993-12-23 Applied Research Systems Ars Holding N.V. Sensor for optical assay
US5922537A (en) * 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
US7094595B2 (en) 2000-10-30 2006-08-22 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
US7309614B1 (en) 2002-12-04 2007-12-18 Sru Biosystems, Inc. Self-referencing biodetection method and patterned bioassays
US7497992B2 (en) 2003-05-08 2009-03-03 Sru Biosystems, Inc. Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers
EP2034295A1 (en) * 2007-09-04 2009-03-11 FUJIFILM Corporation Biosensor capable of simultaneous detection of substrate binding and reaction product
US7951583B2 (en) 2006-03-10 2011-05-31 Plc Diagnostics, Inc. Optical scanning system
US8111401B2 (en) 1999-11-05 2012-02-07 Robert Magnusson Guided-mode resonance sensors employing angular, spectral, modal, and polarization diversity for high-precision sensing in compact formats
US8288157B2 (en) 2007-09-12 2012-10-16 Plc Diagnostics, Inc. Waveguide-based optical scanning systems
US8675199B2 (en) 2006-03-10 2014-03-18 Plc Diagnostics, Inc. Waveguide-based detection system with scanning light source
US8747751B2 (en) 2008-06-16 2014-06-10 Plc Diagnostics, Inc. System and method for nucleic acids sequencing by phased synthesis
US9134307B2 (en) 2007-07-11 2015-09-15 X-Body, Inc. Method for determining ion channel modulating properties of a test reagent
US9778267B2 (en) 2007-07-11 2017-10-03 X-Body, Inc. Methods for identifying modulators of ion channels
US10359573B2 (en) 1999-11-05 2019-07-23 Board Of Regents, The University Of Texas System Resonant waveguide-granting devices and methods for using same

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3236199B2 (en) * 1995-08-25 2001-12-10 日本電気株式会社 Planar optical waveguide type biochemical sensor
DE19601488C1 (en) 1996-01-17 1997-05-28 Itt Ind Gmbh Deutsche Measuring device manufacturing method for measuring or testing physiological parameter at biocomponent
US6611634B2 (en) * 1996-03-19 2003-08-26 University Of Utah Research Foundation Lens and associatable flow cell
US6232124B1 (en) 1996-05-06 2001-05-15 Verification Technologies, Inc. Automated fingerprint methods and chemistry for product authentication and monitoring
US6368795B1 (en) 1998-02-02 2002-04-09 Signature Bioscience, Inc. Bio-assay device and test system for detecting molecular binding events
US6395480B1 (en) 1999-02-01 2002-05-28 Signature Bioscience, Inc. Computer program and database structure for detecting molecular binding events
US6338968B1 (en) 1998-02-02 2002-01-15 Signature Bioscience, Inc. Method and apparatus for detecting molecular binding events
IL139631A0 (en) * 1998-05-13 2002-02-10 Ddx Inc Enumeration method of analyte detection
US6429023B1 (en) 1998-07-20 2002-08-06 Shayda Technologies, Inc. Biosensors with polymeric optical waveguides
CN1237338C (en) 1998-11-13 2006-01-18 莱卡微系统公司 Refractometer and method for qualitative and quantitive measurements
US6244214B1 (en) 1999-01-06 2001-06-12 Embrex, Inc. Concurrent in ovo injection and detection method and apparatus
US6490030B1 (en) 1999-01-18 2002-12-03 Verification Technologies, Inc. Portable product authentication device
US6512580B1 (en) 1999-10-27 2003-01-28 Verification Technologies, Inc. Method and apparatus for portable product authentication
US6399295B1 (en) 1999-12-17 2002-06-04 Kimberly-Clark Worldwide, Inc. Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors
US20040000787A1 (en) * 2000-04-24 2004-01-01 Rakesh Vig Authentication mark for a product or product package
US20030112423A1 (en) * 2000-04-24 2003-06-19 Rakesh Vig On-line verification of an authentication mark applied to products or product packaging
US7124944B2 (en) * 2000-06-30 2006-10-24 Verification Technologies, Inc. Product packaging including digital data
US6638593B2 (en) * 2000-06-30 2003-10-28 Verification Technologies, Inc. Copy-protected optical media and method of manufacture thereof
AU2001259033A1 (en) 2000-06-30 2002-01-14 Verification Technologies, Inc. Copy-protected optical media and method of manufacture thereof
US7660415B2 (en) * 2000-08-03 2010-02-09 Selinfreund Richard H Method and apparatus for controlling access to storage media
US7348182B2 (en) * 2000-10-03 2008-03-25 Mirari Biosciences, Inc. Directed microwave chemistry
US20040209303A1 (en) 2000-10-03 2004-10-21 Martin Mark T. Methods and compositions for directed microwave chemistry
AU2002211317A1 (en) * 2000-10-03 2002-04-15 Mirari Biosciences, Inc. Methods and compositions for directed microwave chemistry
WO2002033005A2 (en) * 2000-10-19 2002-04-25 Trans Photonics, L.L.C. Novel substituted-polyaryl chromophoric compounds
US20030092075A1 (en) * 2000-10-30 2003-05-15 Sru Biosystems, Llc Aldehyde chemical surface activation processes and test methods for colorimetric resonant sensors
US7070987B2 (en) 2000-10-30 2006-07-04 Sru Biosystems, Inc. Guided mode resonant filter biosensor using a linear grating surface structure
US7306827B2 (en) * 2000-10-30 2007-12-11 Sru Biosystems, Inc. Method and machine for replicating holographic gratings on a substrate
US7615339B2 (en) * 2000-10-30 2009-11-10 Sru Biosystems, Inc. Method for producing a colorimetric resonant reflection biosensor on rigid surfaces
US7875434B2 (en) * 2000-10-30 2011-01-25 Sru Biosystems, Inc. Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor
US7300803B2 (en) * 2000-10-30 2007-11-27 Sru Biosystems, Inc. Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor
US6951715B2 (en) * 2000-10-30 2005-10-04 Sru Biosystems, Inc. Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements
US7153702B2 (en) * 2000-10-30 2006-12-26 Sru Biosystems, Inc. Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor
US7371562B2 (en) * 2000-10-30 2008-05-13 Sru Biosystems, Inc. Guided mode resonant filter biosensor using a linear grating surface structure
US7175980B2 (en) * 2000-10-30 2007-02-13 Sru Biosystems, Inc. Method of making a plastic colorimetric resonant biosensor device with liquid handling capabilities
US7264973B2 (en) * 2000-10-30 2007-09-04 Sru Biosystems, Inc. Label-free methods for performing assays using a colorimetric resonant optical biosensor
US7575939B2 (en) * 2000-10-30 2009-08-18 Sru Biosystems, Inc. Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements
US7142296B2 (en) * 2000-10-30 2006-11-28 Sru Biosystems, Inc. Method and apparatus for detecting biomolecular interactions
US7202076B2 (en) 2000-10-30 2007-04-10 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
US7101660B2 (en) 2000-10-30 2006-09-05 Sru Biosystems, Inc. Method for producing a colorimetric resonant reflection biosensor on rigid surfaces
US7217574B2 (en) * 2000-10-30 2007-05-15 Sru Biosystems, Inc. Method and apparatus for biosensor spectral shift detection
US7023544B2 (en) 2000-10-30 2006-04-04 Sru Biosystems, Inc. Method and instrument for detecting biomolecular interactions
US20030113766A1 (en) * 2000-10-30 2003-06-19 Sru Biosystems, Llc Amine activated colorimetric resonant biosensor
US6750033B2 (en) * 2001-05-07 2004-06-15 Agentase, Llc Positive response biosensors and other sensors
US6785432B2 (en) * 2001-06-15 2004-08-31 The Regents Of The University Of California Target molecules detection by waveguiding in a photonic silicon membrane
US7155076B2 (en) * 2001-06-15 2006-12-26 The Regents Of The University Of California Target molecules detection by waveguiding in a photonic silicon membrane
US7102752B2 (en) * 2001-12-11 2006-09-05 Kimberly-Clark Worldwide, Inc. Systems to view and analyze the results from diffraction-based diagnostics
US20050084645A1 (en) * 2002-02-07 2005-04-21 Selinfreund Richard H. Method and system for optical disc copy-protection
US7214530B2 (en) * 2002-05-03 2007-05-08 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
US7223534B2 (en) * 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7771922B2 (en) * 2002-05-03 2010-08-10 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic device
US7223368B2 (en) * 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7091049B2 (en) * 2002-06-26 2006-08-15 Kimberly-Clark Worldwide, Inc. Enhanced diffraction-based biosensor devices
US20040023397A1 (en) * 2002-08-05 2004-02-05 Rakesh Vig Tamper-resistant authentication mark for use in product or product packaging authentication
US7927822B2 (en) * 2002-09-09 2011-04-19 Sru Biosystems, Inc. Methods for screening cells and antibodies
US7429492B2 (en) * 2002-09-09 2008-09-30 Sru Biosystems, Inc. Multiwell plates with integrated biosensors and membranes
JP2006501547A (en) * 2002-09-26 2006-01-12 ベリフィケーション テクノロジーズ インコーポレーション Product certification using temporary optical state change materials
US20060203700A1 (en) * 2003-02-06 2006-09-14 Verification Technologies, Inc. Method and system for optical disk copy-protection
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7687239B2 (en) 2003-07-12 2010-03-30 Accelrs Technology Corporation Sensitive and rapid determination of antimicrobial susceptibility
US8298780B2 (en) * 2003-09-22 2012-10-30 X-Body, Inc. Methods of detection of changes in cells
JP2005098788A (en) * 2003-09-24 2005-04-14 Fuji Photo Film Co Ltd Device for measuring surface plasmon resonance, and sensor unit
EP1680679A2 (en) * 2003-11-06 2006-07-19 SRU Biosystems Inc. High-density amine-functionalized surface
US20050112703A1 (en) * 2003-11-21 2005-05-26 Kimberly-Clark Worldwide, Inc. Membrane-based lateral flow assay devices that utilize phosphorescent detection
US7815854B2 (en) * 2004-04-30 2010-10-19 Kimberly-Clark Worldwide, Inc. Electroluminescent illumination source for optical detection systems
US20060019265A1 (en) * 2004-04-30 2006-01-26 Kimberly-Clark Worldwide, Inc. Transmission-based luminescent detection systems
US7796266B2 (en) * 2004-04-30 2010-09-14 Kimberly-Clark Worldwide, Inc. Optical detection system using electromagnetic radiation to detect presence or quantity of analyte
US7410784B2 (en) * 2004-09-08 2008-08-12 Bayer Corporation Quantitation of enzyme activity using planar waveguides
DE102004046618A1 (en) * 2004-09-25 2006-03-30 Robert Bosch Gmbh Circuit arrangement for analog / digital conversion
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060217446A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating trichomonas vaginitis
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US20070121113A1 (en) * 2004-12-22 2007-05-31 Cohen David S Transmission-based optical detection systems
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
US7713689B2 (en) 2005-09-15 2010-05-11 Duke University Non-fouling polymeric surface modification and signal amplification method for biomolecular detection
US9976192B2 (en) 2006-03-10 2018-05-22 Ldip, Llc Waveguide-based detection system with scanning light source
US9423397B2 (en) 2006-03-10 2016-08-23 Indx Lifecare, Inc. Waveguide-based detection system with scanning light source
US9528939B2 (en) 2006-03-10 2016-12-27 Indx Lifecare, Inc. Waveguide-based optical scanning systems
US7375808B2 (en) * 2006-09-28 2008-05-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and system for sensing and identifying foreign particles in a gaseous environment
WO2008055080A2 (en) * 2006-10-31 2008-05-08 Sru Biosystems, Inc. Method for blocking non-specific protein binding on a functionalized surface
CA2683082A1 (en) * 2007-04-19 2008-10-30 Sru Biosystems, Inc. Method for employing a biosensor to detect small molecules that bind directly to immobilized targets
US8796184B2 (en) 2008-03-28 2014-08-05 Sentilus, Inc. Detection assay devices and methods of making and using the same
US8257936B2 (en) 2008-04-09 2012-09-04 X-Body Inc. High resolution label free analysis of cellular properties
EP2304500A1 (en) * 2008-06-04 2011-04-06 SRU Biosystems, Inc. Detection of promiscuous small submicrometer aggregates
US8321148B2 (en) * 2008-10-24 2012-11-27 Amicus Therapeutics, Inc. Multiple compartment dosing model
US20100273185A1 (en) * 2009-04-27 2010-10-28 Sru Biosystems, Inc. Detection of Biased Agonist Activation
CN102460171A (en) * 2009-05-15 2012-05-16 Sru生物系统公司 Detection of changes in cell populations and mixed cell populations
US8786852B2 (en) 2009-12-02 2014-07-22 Lawrence Livermore National Security, Llc Nanoscale array structures suitable for surface enhanced raman scattering and methods related thereto
US20110237535A1 (en) * 2010-03-26 2011-09-29 Sru Biosystems, Inc. Use of Induced Pluripotent Cells and other Cells for Screening Compound Libraries
EP2571421B1 (en) 2010-05-17 2017-08-02 Sentilus Holdco, LLC Detection devices and related methods of use
ES2551922T3 (en) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Rapid cell purification systems
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9395304B2 (en) 2012-03-01 2016-07-19 Lawrence Livermore National Security, Llc Nanoscale structures on optical fiber for surface enhanced Raman scattering and methods related thereto
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10018566B2 (en) 2014-02-28 2018-07-10 Ldip, Llc Partially encapsulated waveguide based sensing chips, systems and methods of use
WO2016138427A1 (en) 2015-02-27 2016-09-01 Indx Lifecare, Inc. Waveguide-based detection system with scanning light source
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10023895B2 (en) 2015-03-30 2018-07-17 Accelerate Diagnostics, Inc. Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing
EP3325966B1 (en) 2015-07-20 2021-01-20 Sentilus Holdco, LLC Chips, detectors, and methods of making and using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006503A2 (en) * 1988-11-29 1990-06-14 Applied Research Systems Ars Holding N.V. Sensor for optical assay
WO1990011510A1 (en) * 1989-03-23 1990-10-04 Amersham International Plc Assay method using surface plasmon resonance spectrometry

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8509491D0 (en) * 1985-04-12 1985-05-15 Plessey Co Plc Optic waveguide biosensors
GB8618133D0 (en) * 1986-07-24 1986-09-03 Pa Consulting Services Biosensors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006503A2 (en) * 1988-11-29 1990-06-14 Applied Research Systems Ars Holding N.V. Sensor for optical assay
WO1990011510A1 (en) * 1989-03-23 1990-10-04 Amersham International Plc Assay method using surface plasmon resonance spectrometry

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLINICAL CHEMISTRY vol. 35, no. 9, 1989, pages 1863 - 1864; A.P.SCHAAP ET AL.: 'Chemiluminescent Substrates for Alkaline Phosphatase: Application to Ultrasensitive Enzyme-Linked Immunoassays and DNA Probes.' cited in the application *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994091A (en) * 1992-06-10 1999-11-30 Applied Research Systems Ars Holding N.V. Optical sensor for enzyme and enzyme substrates
WO1993025892A1 (en) * 1992-06-10 1993-12-23 Applied Research Systems Ars Holding N.V. Sensor for optical assay
US5922537A (en) * 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
US8111401B2 (en) 1999-11-05 2012-02-07 Robert Magnusson Guided-mode resonance sensors employing angular, spectral, modal, and polarization diversity for high-precision sensing in compact formats
US10359573B2 (en) 1999-11-05 2019-07-23 Board Of Regents, The University Of Texas System Resonant waveguide-granting devices and methods for using same
US7094595B2 (en) 2000-10-30 2006-08-22 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
US7309614B1 (en) 2002-12-04 2007-12-18 Sru Biosystems, Inc. Self-referencing biodetection method and patterned bioassays
US7497992B2 (en) 2003-05-08 2009-03-03 Sru Biosystems, Inc. Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers
US8675199B2 (en) 2006-03-10 2014-03-18 Plc Diagnostics, Inc. Waveguide-based detection system with scanning light source
US8187866B2 (en) 2006-03-10 2012-05-29 Plc Diagnostics, Inc. Optical scanning system
US7951583B2 (en) 2006-03-10 2011-05-31 Plc Diagnostics, Inc. Optical scanning system
US9134307B2 (en) 2007-07-11 2015-09-15 X-Body, Inc. Method for determining ion channel modulating properties of a test reagent
US9778267B2 (en) 2007-07-11 2017-10-03 X-Body, Inc. Methods for identifying modulators of ion channels
US11016100B2 (en) 2007-07-11 2021-05-25 X-Body, Inc. Methods for identifying modulators of ion channels
US7993912B2 (en) 2007-09-04 2011-08-09 Fujifilm Corporation Biosensor capable of simultaneous detection of substrate binding and reaction product
EP2034295A1 (en) * 2007-09-04 2009-03-11 FUJIFILM Corporation Biosensor capable of simultaneous detection of substrate binding and reaction product
US8288157B2 (en) 2007-09-12 2012-10-16 Plc Diagnostics, Inc. Waveguide-based optical scanning systems
US8747751B2 (en) 2008-06-16 2014-06-10 Plc Diagnostics, Inc. System and method for nucleic acids sequencing by phased synthesis

Also Published As

Publication number Publication date
GB9111912D0 (en) 1991-07-24
US5496701A (en) 1996-03-05
EP0588831A1 (en) 1994-03-30
JPH06507708A (en) 1994-09-01

Similar Documents

Publication Publication Date Title
US5496701A (en) Optical biosensor method for determining an analyte
Attridge et al. Sensitivity enhancement of optical immunosensors by the use of a surface plasmon resonance fluoroimmunoassay
US6395558B1 (en) Optical chemical/biochemical sensor
AU625324B2 (en) Sensor for optical assay
US5478755A (en) Long range surface plasma resonance immunoassay
US5415842A (en) Surface plasmon resonance analytical device
US5434663A (en) Analytical device
US5830766A (en) Enhanced signal-to-noise ratio and sensitivity optical immunoassay
EP0760944B1 (en) Process for detecting evanescently excited luminescence
US5071248A (en) Optical sensor for selective detection of substances and/or for the detection of refractive index changes in gaseous, liquid, solid and porous samples
US5832165A (en) Composite waveguide for solid phase binding assays
Brecht et al. Label free optical immunoprobes for pesticide detection
JPH10307141A (en) Method for simultaneously detecting mutual reaction of organism molecule using plasmon resonance and fluorescent detection
EP0382832B1 (en) Method of assay fora ligand in a sample
EP0500611B1 (en) Analytical device and methods
EP0543842A1 (en) Analytical device.
EP0321523B1 (en) Waveguide sensor
JPS638560A (en) Immunological analytic system
US20190056389A1 (en) System and method for determining the presence or absence of adsorbed biomolecules or biomolecular structures on a surface
KR20200021571A (en) High-sensitivity ellipsometry-based biosensing technique by using a tracer having high absorption coefficient and a dielectric substrate
WO1991004489A1 (en) A homogeneous interferometric immunoassay system
Yoshida et al. Sensitivity enhancement of evanescent wave immunoassay
Hall Developing biosensors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992910808

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 08157079

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1992910808

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1992910808

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992910808

Country of ref document: EP